Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vaginal swabs of women with acute SARS-CoV-2 infection: a prospective study.
Severe acute respiratory syndrome coronavirus 2
vaginal secretion
Journal
BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
24
08
2020
revised:
24
09
2020
accepted:
28
09
2020
pubmed:
7
10
2020
medline:
22
12
2020
entrez:
6
10
2020
Statut:
ppublish
Résumé
To determine whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is present in the vaginal secretions of both reproductive-aged and postmenopausal women during acute SARS-CoV-2 infection. Prospective study. A single tertiary, university-affiliated medical centre in Israel. Time period, 1 June 2020 through to 31 July 2020. Women who were hospitalised in a single tertiary medical centre, who were diagnosed with acute SARS-CoV-2 infection by a nasopharyngeal RT-PCR test. Women were diagnosed with acute SARS-CoV-2 infection by a nasopharyngeal RT-PCR test. Vaginal RT-PCR swabs were obtained from all study participants after a proper cleansing of the perineum. Detection of SARS-CoV-2 in vaginal RT-PCR swabs. Vaginal and nasopharyngeal swabs were obtained from 35 women, aged 21-93 years. Twenty-one women (60%) were in their reproductive years, of whom, five were in their third trimester of pregnancy. Most of the participants (57%) were healthy without any underlying medical conditions. Of the 35 patients sampled, 2 (5.7%) had a positive vaginal RT-PCR for SARS-CoV-2, one was premenopausal and the other was a postmenopausal woman. Both women had mild disease. Our findings contradict most previous reports, which did not detect the presence of viral colonisation in the vagina. Although passage through the birth canal exposes neonates to the vaginal polymicrobial flora, an acquisition of pathogens does not necessarily mandate neonatal infection or clinical disease. Nevertheless, when delivering the infant of a woman with acute SARS-CoV-2 infection, a clinician should consider the possibility of vaginal colonisation, even if it is uncommon. When delivering the infant of a woman with acute SARS-CoV-2 infection, a clinician should consider the possibility of vaginal colonisation.
Identifiants
pubmed: 33021026
doi: 10.1111/1471-0528.16556
pmc: PMC7675593
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
97-100Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Am J Obstet Gynecol. 2020 Jul;223(1):131-134
pubmed: 32376320
QJM. 2001 Oct;94(10):521-6
pubmed: 11588210
Lancet Infect Dis. 2020 May;20(5):559-564
pubmed: 32220284
J Matern Fetal Neonatal Med. 2020 Jul 16;:1-3
pubmed: 32669014
BJOG. 2021 Jan;128(1):97-100
pubmed: 33021026
Nat Commun. 2020 Jul 14;11(1):3572
pubmed: 32665677
Obstet Gynecol. 2020 Feb;135(2):e51-e72
pubmed: 31977795
JAMA Netw Open. 2020 May 1;3(5):e208292
pubmed: 32379329
Clin Infect Dis. 2020 Jul 28;71(15):813-817
pubmed: 32241022
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):418-423
pubmed: 32114744
JAMA. 2020 May 12;323(18):1846-1848
pubmed: 32215581
JAMA Pediatr. 2020 Jul 1;174(7):722-725
pubmed: 32215598
Clin Infect Dis. 2020 Mar 17;:
pubmed: 32182347